The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Renal Vulnerability to Drug Toxicity
Abstract
Drug-induced kidney disease occurs primarily in patients with underlying risk factors. A number of factors enhance the vulnerability of the kidney to the nephrotoxic effects of drugs and toxins. They are broadly categorized as patient-specific, kidney-related, and drug-related factors. One, two, or all three of the factor categories can act to promote various forms of renal injury. Importantly, all compartments of the kidney can be affected and result in one or more classic clinical renal syndromes. These include acute kidney injury, various tubulopathies, proteinuric renal disease, and chronic kidney disease. Recognizing risk factors that increase renal vulnerability to drug-induced kidney disease is the first step in reducing the renal complications of drugs and toxins.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Yang, J. C., Haworth, L., Sherry, R. M., Hwu, P., Schwartzentruber, D. J., Topalian, S. L., Steinberg, S. M., Chen, H. X., & Rosenberg, S. A. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa021491 · Cited by 2,697
VEGF Inhibition and Renal Thrombotic Microangiopathy
Eremina, V., Jefferson, J. A., Kowalewska, J., Hochster, H., Haas, M., Weisstuch, J., Richardson, C., Kopp, J. B., Kabir, M. G., Backx, P. H., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0707330 · Cited by 1,504
Non-steroidal anti-inflammatory drugs for cancer prevention: promise, perils and pharmacogenetics
Ulrich, C. M., Bigler, J., & Potter, J. D. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1801 · Cited by 548
Sugimoto, H., Hamano, Y., Charytan, D., Cosgrove, D., Kieran, M., Sudhakar, A., & Kalluri, R. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.c300012200 · Cited by 538
Cisplatin Nephrotoxicity Is Critically Mediated via the Human Organic Cation Transporter 2
Ciarimboli, G., Ludwig, T., Lang, D., Pavenstädt, H., Koepsell, H., Piechota, H.-J., Haier, J., Jaehde, U., Zisowsky, J., & Schlatter, E. (2005) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)61234-5 · Cited by 448
Antiviral Drug-Induced Nephrotoxicity
Izzedine, H., Launay-Vacher, V., & Deray, G. (2005) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2005.02.010 · Cited by 423
Toxic acute tubular necrosis following treatment with zoledronate (Zometa)
Markowitz, G. S., Fine, P. L., Stack, J. I., Kunis, C. L., Radhakrishnan, J., Palecki, W., Park, J., Nasr, S. H., Hoh, S., Siegel, D. S., et al. (2003) · Kidney International · doi:10.1046/j.1523-1755.2003.00071.x · Cited by 384
Anticancer Drug???Induced Kidney Disorders: Incidence, Prevention and Management
Kintzel, P. E. (2001) · Drug Safety · doi:10.2165/00002018-200124010-00003 · Cited by 355
Drug-induced acute kidney injury
Schetz, M., Dasta, J., Goldstein, S., & Golper, T. (2005) · Current Opinion in Critical Care · doi:10.1097/01.ccx.0000184300.68383.95 · Cited by 313
Nagai, J., & Takano, M. (2004) · Drug Metabolism and Pharmacokinetics · doi:10.2133/dmpk.19.159 · Cited by 297
Drug-Induced Urinary Retention: Incidence, Management and Prevention
Verhamme, K. M. C., Sturkenboom, M. C. J. M., Stricker, B. H. C., & Bosch, R. (2008) · Drug Safety · doi:10.2165/00002018-200831050-00002 · Cited by 264
Isnard Bagnis, C., Deray, G., Baumelou, A., Le Quintrec, M., & Vanherweghem, J. L. (2004) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2004.02.009 · Cited by 244
Association between ABCC2 Gene Haplotypes and Tenofovir‐Induced Proximal Tubulopathy
Izzedine, H., Hulot, J., Villard, E., Goyenvalle, C., Dominguez, S., Ghosn, J., Valantin, M. A., Lechat, P., & Deray, A. G. (2006) · The Journal of Infectious Diseases · doi:10.1086/508546 · Cited by 243
Gambaro, G., & Perazella, M. A. (2003) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.2003.01146.x · Cited by 225
Self-citationHigh Sirolimus Levels May Induce Focal Segmental Glomerulosclerosis De Novo
Letavernier, E., Bruneval, P., Mandet, C., Van Huyen, J.-P. D., Pe[Combining Acute Accent]raldi, M.-N. D., Helal, I., Noe[Combining Diaeresis]l, L.-H. A. A. G. A., & Legendre, C. (2007) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.03751106 · Cited by 200
The renal effects of nonsteroidal anti-inflammatory drugs: Summary and recommendations
Bennett, W. M., Henrich, W. L., & Stoff, J. S. (1996) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(96)90570-3 · Cited by 194
Drug-induced renal failure: a focus on tubulointerstitial disease
Markowitz, G. S., & Perazella, M. A. (2005) · Clinica Chimica Acta · doi:10.1016/j.cccn.2004.09.005 · Cited by 185
Self-citationWyatt, C. M., Arons, R. R., Klotman, P. E., & Klotman, M. E. (2006) · AIDS · doi:10.1097/01.aids.0000210610.52836.07 · Cited by 184
Enomoto, A., & Endou, H. (2005) · Clinical and Experimental Nephrology · doi:10.1007/s10157-005-0368-5 · Cited by 181
Renal Effects of Anti-angiogenesis Therapy: Update for the Internist
Gurevich, F., & Perazella, M. A. (2009) · The American Journal of Medicine · doi:10.1016/j.amjmed.2008.11.025 · Cited by 170
Self-citationThe safety of gadolinium in patients with stage 3 and 4 renal failure
Ergün, I., Keven, K., Uruç, I., Ekmekçi, Y., Canbakan, B., Erden, I., & Karatan, O. (2006) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfi304 · Cited by 158
Involvement of Drug-Specific T Cells in Acute Drug-Induced Interstitial Nephritis
Spanou, Z., Keller, M., Britschgi, M., Yawalkar, N., Fehr, T., Neuweiler, J., Gugger, M., Mohaupt, M., & Pichler, W. J. (2006) · Journal of the American Society of Nephrology · doi:10.1681/asn.2006050418 · Cited by 151 · cited 2×
“Salt wasting from loop or distal nephron tubular injury is seen with cisplatin and aminoglycosides (acquired Bartter syndrome) (1,4,31,33).”
BackgroundToxic nephropathy: environmental chemicals
Vleet, T. R. V., & Schnellmann, R. G. (2003) · Seminars in Nephrology · doi:10.1016/s0270-9295(03)00094-9 · Cited by 146
Proton pump inhibitors and the kidney: critical review
Brewster, U. C., & Perazella, M. A. (2007) · Clinical Nephrology · doi:10.5414/cnp68065 · Cited by 137
Self-citationIntravenous immunoglobulin and the kidney—a two-edged sword
Orbach, H., Tishler, M., & Shoenfeld, Y. (2004) · Seminars in Arthritis and Rheumatism · doi:10.1016/j.semarthrit.2004.06.003 · Cited by 134
Acute renal failure in cancer patients
Lameire, N. H., Flombaum, C. D., Moreau, D., & Ronco, C. (2005) · Annals of Medicine · doi:10.1080/07853890510007205 · Cited by 130
Yu, C., Lin, J., & Lin‐Tan, D. (2004) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000118529.01681.4f · Cited by 123
How to prevent, recognize, and treat drug-induced nephrotoxicity.
Guo, X., & Nzerue, C. M. (2002) · Cleveland Clinic Journal of Medicine · doi:10.3949/ccjm.69.4.289 · Cited by 112
Renal Transport of Antibiotics and Nephrotoxicity: a Review
Fanos, V., & Cataldi, L. (2001) · Journal of Chemotherapy · doi:10.1179/joc.2001.13.5.461 · Cited by 110
Cytochrome P450 3A and 2B6 in the developing kidney: implications for ifosfamide nephrotoxicity
Aleksa, K., Matsell, D. G., Krausz, K., Gelboin, H. V., Ito, S., & Koren, G. (2005) · Pediatric Nephrology · doi:10.1007/s00467-004-1807-3 · Cited by 82
Singh, N. P., Ganguli, A., & Prakash, A. (2003) · PubMed · Cited by 78
Study of Renal Safety in Amphotericin B Lipid Complex–Treated Patients
Alexander, B. D., & Wingard, J. R. (2005) · Clinical Infectious Diseases · doi:10.1086/429335 · Cited by 73
Jerkić, M., Vojvodić, S., & López-Novoa, J. M. (2001) · International Urology and Nephrology · doi:10.1023/a:1014484101427 · Cited by 65
Evenepoel, P. (2004) · Best practice & research. Clinical anaesthesiology · doi:10.1016/j.bpa.2003.09.007 · Cited by 62
Increased propensity for calcium phosphate kidney stones with topiramate use
Vega, D., Maalouf, N. M., & Sakhaee, K. (2007) · Expert Opinion on Drug Safety · doi:10.1517/14740338.6.5.547 · Cited by 62
Ciprofloxacin Crystal Nephropathy
Stratta, P., Lazzarich, E., Canavese, C., Bozzola, C., & Monga, G. (2007) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2007.05.014 · Cited by 56
Aminoglycoside Dosages and Nephrotoxicity
Rougier, F., Ducher, M., Maurin, M., Corvaisier, S., Claude, D., Jelliffe, R. W., & Maire, P. H. (2003) · Clinical Pharmacokinetics · doi:10.2165/00003088-200342050-00007 · Cited by 55
Electrolyte and acid-base disorders associated with AIDS
Perazella, M. A., & Brown, E. (1994) · Journal of General Internal Medicine · doi:10.1007/bf02600132 · Cited by 52
Self-citationZonisamide and renal calculi in patients with epilepsy: how big an issue?
Wroe, S. J. (2007) · Current Medical Research and Opinion · doi:10.1185/030079907x210499 · Cited by 45
Elseviers, M. M., & Broe, M. E. D. (1999) · Drug Safety · doi:10.2165/00002018-199920010-00003 · Cited by 37
Aminoglycoside-associated nephrotoxicity in extrahepatic obstructive jaundice
Lucena, M. I., Andrade, R. J., Cabello, M. R., Hidalgo, R., Correa, J. A. G., & de la Cuesta, F. S. (1995) · Journal of Hepatology · doi:10.1016/0168-8278(95)80428-5 · Cited by 35
Nephrotoxicity of over-the-counter analgesics, natural medicines, and illicit drugs
Blowey, D. L. (2005) · Adolescent Medicine Clinics · doi:10.1016/j.admecli.2004.10.001 · Cited by 33
Race and Ethnicity in the Era of Emerging Pharmacogenomics
Harty, L. C., Johnson, K. J., & Power, A. (2006) · The Journal of Clinical Pharmacology · doi:10.1177/0091270005286028 · Cited by 27
Cited by
Human kidney proximal tubule-on-a-chip for drug transport and nephrotoxicity assessment
Jang, K.-J., Mehr, A. P., Hamilton, G. A., McPartlin, L. A., Chung, S., Suh, K.-Y., & Ingber, D. E. (2013) · Integrative Biology · doi:10.1039/c3ib40049b · Cited by 849
Side effects of methotrexate therapy for rheumatoid arthritis: A systematic review
Wang, W., Zhou, H., & Liu, L. (2018) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2018.09.027 · Cited by 562
Next-generation biomarkers for detecting kidney toxicity
Bonventre, J. V., Vaidya, V. S., Schmouder, R., Feig, P., & Dieterle, F. (2010) · Nature Biotechnology · doi:10.1038/nbt0510-436 · Cited by 538
Organ-on-a chip systems: microengineering to biomimic living systems
Zheng, F., Fu, F., Cheng, Y., Wang, C., Zhao, Y., & Gu, Z. (2016) · Small · doi:10.1002/smll.201503208 · Cited by 338
Perazella, M. A., & Moeckel, G. W. (2010) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2010.09.005 · Cited by 287
Self-citation
Metadata
- Authors
- Perazella, M. A.
- Venue
- Clinical Journal of the American Society of Nephrology
- Published
- 2009-07
- Volume
- 4
- Issue
- 7
- Pages
- 1275-1283
- ISSN
- 1555-9041 (ISSN-L)
- OpenAlex
- W2118884380
- Cited by
- 403
- References
- 43
- FWCI
- 5.77
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.